Novo Nordisk China Restructures to Form New Obesity and Diabetes Department
Company

Novo Nordisk China Restructures to Form New Obesity and Diabetes Department

Eli Lilly Partners with Juvena Therapeutics on Muscle Health AI Platform
CompanyDeals

Eli Lilly Partners with Juvena Therapeutics on Muscle Health AI Platform

Daiichi Sankyo Launches Phase I Trial for Enhertu Subcutaneous Formulation
CompanyDrug

Daiichi Sankyo Launches Phase I Trial for Enhertu Subcutaneous Formulation

NMPA Issues Immediate Guidelines for NGS-Related IVD Reagent Classification
Medical DevicePolicy / Regulatory

NMPA Issues Immediate Guidelines for NGS-Related IVD Reagent Classification

China Updates Class 3 Hospital Accreditation Standards for 2025
Policy / Regulatory

China Updates Class 3 Hospital Accreditation Standards for 2025

Huadong Medicine Receives NMPA Approval for Phase III Trial of Roflumilast Foam
CompanyDrug

Huadong Medicine Receives NMPA Approval for Phase III Trial of Roflumilast Foam

China's Sichuan Kelun-Biotech Wins BTD for Sac-TMT in Non-Squamous NSCLC
CompanyDrug

China’s Sichuan Kelun-Biotech Wins BTD for Sac-TMT in Non-Squamous NSCLC

China's CDE Seeks Feedback on Advanced Therapy Medicinal Products Guidelines
Policy / Regulatory

China’s CDE Seeks Feedback on Advanced Therapy Medicinal Products Guidelines

Philochem Grants RayzeBio Global Rights to OncoACP3 for Prostate Cancer
CompanyDeals

Philochem Grants RayzeBio Global Rights to OncoACP3 for Prostate Cancer

Henlius Biotech Starts Global Phase II Trial for PD-L1 ADC HLX43
CompanyDrug

Henlius Biotech Starts Global Phase II Trial for PD-L1 ADC HLX43

Tawada Healthcare Secures Series A+ Funding Led by Highlight Capital
CompanyDeals

Tawada Healthcare Secures Series A+ Funding Led by Highlight Capital

Merck's Pimicotinib NDA Accepted for Review by China's CDE
CompanyDrug

Merck’s Pimicotinib NDA Accepted for Review by China’s CDE